BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Scoville SD, Xourafas D, Ejaz AM, Tsung A, Pawlik T, Cloyd JM. Contemporary indications for and outcomes of hepatic resection for neuroendocrine liver metastases. World J Gastrointest Surg 2020; 12(4): 159-170 [PMID: 32426095 DOI: 10.4240/wjgs.v12.i4.159]
URL: https://www.wjgnet.com/1007-9327/full/v12/i4/159.htm
Number Citing Articles
1
S. Nadalin, M. Peters, A. Königsrainer. Lebermetastasen neuroendokriner TumorenDie Chirurgie 2022; 93(7): 659 doi: 10.1007/s00104-022-01656-1
2
Kylie E Zane, Jordan M Cloyd, Khalid S Mumtaz, Vibhor Wadhwa, Mina S Makary. Metastatic disease to the liver: Locoregional therapy strategies and outcomesWorld Journal of Clinical Oncology 2021; 12(9): 725-745 doi: 10.5306/wjco.v12.i9.725
3
Jason L Schwarz, Kristine M Kuchta, Aram Rojas, Syed Mehdi, Sung Hoon Choi, Xavier M Keutgen, Mark S Talamonti, Melissa E Hogg. Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database StudyJournal of the American College of Surgeons 2023; 237(1): 157 doi: 10.1097/XCS.0000000000000701
4
Steven D Scoville, Jordan M Cloyd, Timothy M Pawlik. Treatment of neuroendocrine liver metastases: a patent landscape reviewPharmaceutical Patent Analyst 2020; 9(2): 29 doi: 10.4155/ppa-2020-0009
5
Francesca Muffatti, Valentina Andreasi, Stefano Partelli, Massimo Falconi. Neuroendocrine Tumors2021; : 125 doi: 10.1007/978-3-030-62241-1_8